OLYMPUS trial shows advantages of roxadustat vs placebo for increasing hemoglobin
Roxadustat shows greater hemoglobin gains compared to epoetin alfa for ESKD
Wearable and implantable devices show potential for kidney failure, but more work needed
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.